In the brain of an AD mouse model, upregulated FTO was also observed to activate the phosphorylation of tau and accelerate the pathological hallmarks of AD in an mTOR-dependent manner (Li et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.